We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Brazilian IVD Market Fueled by Growing Demand

By LabMedica International staff writers
Posted on 03 Jul 2017
Print article
Brazil's in vitro diagnostic (IVD) market is one of the largest, driven by increasing interest in molecular testing technologies, prenatal screening, and point-of-care (POC) glucose testing. Brazil, which has a growing middle class, stabilizing economy, increasing urban population, and a supportive government, is witnessing a major shift toward the private health industry, which supports the growth of IVD technologies that are expensive or not typically covered at the public level. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Brazil is the world’s sixth most populated country with 205.8 million people residing in the country in 2016 and has a market worth over USD 900 million. Brazil is also the largest country in Latin America in terms of population, accounting for a share of 33% of the region's total population. Brazil’s population distribution is expected to shift toward the 65 years and above age group, which will account for 21% of its total population by 2050, up from 7% in 2010. This shift in the country’s aging population is expected to lead to an increase in the incidence of diseases, as an aging population is more vulnerable to illness.

The business environment for medical devices and equipment is favorable in Brazil and holds promise for players who are interested in expanding into the country’s IVD market. Brazilian health professionals as well as patients are demanding innovative diagnostic products, targeting infectious diseases and cancer, aided by the country’s stabilizing economic condition and growing middle class population. Brazil's healthcare system relies on both public and private spending, with private health spending being higher at 53% in the private sector as against 47% for the public sector. The middle class, which is responsible for the country’s growing private health insurance industry, expects faster results, with test turnaround times being a priority among the patients.

As a result, there is increasing demand for advanced testing technologies, higher sensitivity and equipment that can meet the requirement for faster results. The demand for new technologies in the laboratory sector, particularly for high-sensitivity testing and high-volume testing equipment, is growing in Brazil. Additionally, increasing investments in medical R&D is further fueling the growth of the market for IVD and laboratory equipment.

The trend of consolidation in the Brazilian laboratory service industry is also stabilizing and the current providers are highly competitive. Currently, four national, or regionally dominating, laboratory service providers are operating in the country, as against around 15 large-volume labs in the early 2000s when consolidation in the industry was intense.

Related Links:
Kalorama Information

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.